Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study

OBJECTIVE: Patients with risk factors for or established atherosclerotic cardiovascular disease (ASCVD) remain at high risk for subsequent ischemic events despite statin therapy. Triglyceride (TG) levels may contribute to residual ASCVD risk, and the performance of global risk assessment calculators...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Jeffrey R., Fitzpatrick, Jesse K., Yang, Jingrong, Sung, Sue Hee, Allen, Amanda R., Philip, Sephy, Granowitz, Craig, Abrahamson, David, Ambrosy, Andrew P., Go, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844399/
https://www.ncbi.nlm.nih.gov/pubmed/35199077
http://dx.doi.org/10.1016/j.ajpc.2022.100319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844399/
https://www.ncbi.nlm.nih.gov/pubmed/35199077
http://dx.doi.org/10.1016/j.ajpc.2022.100319

Ejemplares similares